Translucent AI is a technology company.
Translucent AI has raised $7.0M across 1 funding round.
Translucent AI has raised $7.0M in total across 1 funding round.
Translucent AI has raised $7.0M in total across 1 funding round.
Translucent AI's investors include New Enterprise Associates, TMV.
Translucent AI is a New York City-based startup founded in 2024 that builds an agentic AI financial analyst platform exclusively for healthcare operators, such as medical groups and health systems.[1][3][5] The product automates manual financial processes by integrating with healthcare-specific systems like general ledgers, EHRs, revenue cycle management, and payer contracts, enabling plain-language queries for real-time insights, forecasts, reports, and performance monitoring—addressing the core problem of finance teams spending most time on data pulling and formatting rather than strategy.[1][5][7] It serves large providers managing over $5 billion in annual revenue, with early deployments yielding testimonials like Springfield Clinic's CEO noting "immediate, actionable insights that were previously out of reach."[1][5] Backed by a $7M oversubscribed seed round led by Virtue VC with NEA, FPV, and Redesign Health, Translucent shows strong growth momentum in a sector where providers face mounting losses amid $2.5 trillion annual flows.[3][5]
Translucent AI was founded in 2024 by CEO Jack O’Hara and co-founder Max Tkachuk, both with deep healthcare operations experience—collectively over 40 years—stemming from personal frustrations with manual, spreadsheet-heavy financial workflows that hinder strategic focus on patients and margins.[1][5][8] O’Hara, a former healthcare operator, identified the "systemic productivity problem" where finance teams drown in data extraction from fragmented systems, inspiring a narrow-focus AI solution tailored to healthcare's unique economics like service-line performance and payer contracts.[1][7] Early traction came swiftly post-launch, with deployments in large organizations and the $7M seed raise in August 2025, validating founder-market fit through their blend of domain expertise, financial acumen, and AI technical prowess.[3][5]
Translucent rides the agentic AI wave in healthcare finance, where traditional FP&A is reactive and siloed amid rising provider losses and economic pressures, timed perfectly as AI costs drop and LLMs mature for domain-specific tasks.[3][5][7] Market forces like $2.5 trillion in provider flows, manual process inefficiencies (70-85% AI project failure rates elsewhere), and demand for non-expert tools favor its narrow focus, enabling margins improvement and faster decisions in a red-ink environment.[2][5][7] It influences the ecosystem by pioneering AI-native finance for healthcare—beyond ChatGPT-like queries to adaptive agents that encode cross-org insights—potentially setting standards for vertical AI in high-stakes sectors and aiding the shift from hype to measurable ROI.[3][7]
Translucent is poised to scale from large providers to mid-market groups, leveraging its flywheel for smarter agents and seed capital for integrations and sales expansion amid agentic AI's rise.[1][3] Trends like escalating healthcare costs, AI workflow maturity, and regulatory pushes for efficiency will propel it, potentially evolving into a full operations platform as data networks grow. With founder expertise and backer momentum, expect Translucent to redefine provider finance clarity—turning opaque pain points into strategic edges that sustain organizations through turbulent economics.[3][5][7]
Translucent AI has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Seed in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 1, 2025 | $7.0M Seed | New Enterprise Associates, TMV |